IP Library Granted Patent US 7,090,866
Granted Patent B2
US 7,090,866 · App. 10/647,761 · Granted Aug 15, 2006

Opioid agonist in a fast dispersing dosage form

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,090,866
App. No.
10/647,761
Granted
Aug 15, 2006
Kind
B2
Abstract

This invention relates to a pharmaceutical composition for oral administration comprising a carrier and, as active ingredient, an opioid (μ receptor) agonist, such as fentanyl, or a salt thereof, characterized in that the composition is in the form of a fast-dispersing dosage form designed to release the active ingredient rapidly in the oral cavity. A process for preparing such a composition and the use of such a composition as an analgesic, for the treatment of chronic pain and/or breakthrough pain, as an anesthetic premedication, for the induction of anesthesia, as a sedative and/or for the treatment of anxiety are also provided.

Claims (12)

1. A pharmaceutical composition for oral administration comprising a carrier and, as active ingredient, an opioid agonist characterized in that the composition is in the form of a fast-dispersing dosage form comprising a network of said active and a water-soluble or water-dispersible carrier which is inert towards said active, said dosage form disintegrates within 1–60 seconds of being placed in the oral cavity.

2. A composition according to claim 1 in which the opioid agonist is fentanyl or a salt thereof.

3. A composition according to claim 1 wherein said network having been obtained by subliming solvent from a composition in the solid state, that composition comprising said active and a solution of the carrier in a solvent.

4. The pharmaceutical composition of claim 1 in which said active ingredient is present in an amount from 0.2 to 95% by weight of the composition.

5. The pharmaceutical composition of claim 2 in which fentanyl or a salt thereof is present in an amount from 0.5 to 10% by weight of the composition.

6. The pharmaceutical composition of claim 2 in which the active ingredient is present in an amount from 0.1 to 200 mg per dosage form.

7. A method of providing anesthetic pre-medication, said method comprising the step of providing to a patient in need thereof the pharmaceutical composition according to claim 1 .

8. A method of inducing anesthesia, said method comprising the step of administering a pharmaceutical composition according to claim 1 to a patient in need thereof.

9. A method of administering an opioid agonist to a patient which comprises introducing into the oral cavity of the patient a composition according to claim 1 .

10. A method of treating pain which comprises introducing into the oral cavity of a patient a therapeutically effective amount of a composition according to claim 1 .

11. The method according to claim 10 in which the pain is chronic pain.

12. The method according to claim 10 in which the patient is experiencing chronic pain and the pain to be treated is breakthrough pain.

Assignments (4)
RELEASE OF SECURITY INTEREST IN PATENT COLLATERAL (019323/0302) Recorded Dec 19, 2024
From: JPMORGAN CHASE BANK, N.A.
To: CATALENT PHARMA SOLUTIONS, LLC; R.P. SCHERER TECHNOLOGIES, INC.; R.P. SCHERER TECHNOLOGIES, LLC; R.P. SCHERER CORPORATION
Reel/Frame 069750/0933 →
NOTICE OF SUCCESSION OF AGENCY Recorded May 17, 2019
From: MORGAN STANLEY SENIOR FUNDING, INC.
To: JPMORGAN CHASE BANK, N.A.
Reel/Frame 049217/0981 →
CHANGE OF NAME Recorded Jul 24, 2007
From: CARDINAL HEALTH 400, INC.; CARDINAL HEALTH 406, LLC; CARDINAL HEALTH 409, INC.; CARDINAL HEALTH 421, INC.; CARDINAL HEALTH PTS, LLC
To: CATALENT USA WOODSTOCK, INC.; CATALENT USA PACKAGING, LLC; CATALENT PHARMA SOLUTIONS, INC.; CATALENT USA PAINTBALL, INC.; CATALENT PHARMA SOLUTIONS, LLC
Reel/Frame 019588/0622 →
SECURITY AGREEMENT Recorded May 22, 2007
From: PTS ACQUISITION CORP.; PTS INTERMEDIATE HOLDINGS LLC; CARDINAL HEALTH 400, INC.; CARDINAL HEALTH 406, LLC; CARDINAL HEALTH 421, INC.; CARDINAL HEALTH PTS, LLC; R.P. SCHERER TECHNOLOGIES, INC.; GLACIER CORPORATION; CARDINAL HEALTH 409, INC.
To: MORGAN STANLEY SENIOR FUNDING, INC.
Reel/Frame 019323/0302 →